$359 Million is the total value of SPHERA FUNDS MANAGEMENT LTD.'s 96 reported holdings in Q4 2013. The portfolio turnover from Q3 2013 to Q4 2013 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| New | JOHNSON & JOHNSONcall | $32,057,000 | – | 350,000 | +100.0% | 8.93% | – | |
| GSK | New | GLAXOSMITHKLINE PLCsponsored adr | $29,365,000 | – | 550,000 | +100.0% | 8.18% | – |
| PFE | New | PFIZER INC | $21,517,000 | – | 702,496 | +100.0% | 5.99% | – |
| New | PFIZER INCcall | $19,974,000 | – | 652,100 | +100.0% | 5.56% | – | |
| XLF | New | SELECT SECTOR SPDR TRsbi materials | $16,676,000 | – | 762,856 | +100.0% | 4.64% | – |
| MRK | New | MERCK & CO INC NEW | $14,014,000 | – | 280,000 | +100.0% | 3.90% | – |
| New | MERCK & CO INC NEWcall | $10,010,000 | – | 200,000 | +100.0% | 2.79% | – | |
| SHPG | New | SHIRE PLCsponsored adr | $9,184,000 | – | 65,000 | +100.0% | 2.56% | – |
| New | GILEAD SCIENCES INCput | $9,018,000 | – | 120,000 | +100.0% | 2.51% | – | |
| New | AMGEN INC | $7,991,000 | – | 70,000 | +100.0% | 2.23% | – | |
| IWM | New | ISHARESmsci aust etf | $7,750,000 | – | 67,209 | +100.0% | 2.16% | – |
| XLV | New | SELECT SECTOR SPDR TRsbi materials | $7,541,000 | – | 136,023 | +100.0% | 2.10% | – |
| QQQ | New | POWERSHARES QQQ TRUSTunit ser 1 | $7,098,000 | – | 80,700 | +100.0% | 1.98% | – |
| GILD | New | GILEAD SCIENCES INC | $7,064,000 | – | 94,000 | +100.0% | 1.97% | – |
| INCY | New | INCYTE CORP | $6,582,000 | – | 130,000 | +100.0% | 1.83% | – |
| TEVA | New | TEVA PHARMACEUTICAL INDS LTDadr | $6,012,000 | – | 150,000 | +100.0% | 1.68% | – |
| XLI | New | SELECT SECTOR SPDR TRsbi materials | $4,945,000 | – | 94,623 | +100.0% | 1.38% | – |
| SGEN | New | SEATTLE GENETICS INC | $4,898,000 | – | 122,800 | +100.0% | 1.36% | – |
| TJX | New | TJX COS INC NEW | $4,156,000 | – | 65,216 | +100.0% | 1.16% | – |
| IRWD | New | IRONWOOD PHARMACEUTICALS INC | $4,005,000 | – | 345,000 | +100.0% | 1.12% | – |
| New | Teva Pharmaceutical Industriescall | $4,008,000 | – | 100,000 | +100.0% | 1.12% | – | |
| P103PS | New | NPS PHARMACEUTICALS INC | $3,886,000 | – | 128,000 | +100.0% | 1.08% | – |
| CHKP | New | CHECK POINT SOFTWARE TECH LTord | $3,571,000 | – | 55,353 | +100.0% | 1.00% | – |
| CL | New | COLGATE PALMOLIVE CO | $3,476,000 | – | 53,299 | +100.0% | 0.97% | – |
| BIIB | New | BIOGEN IDEC INC | $3,357,000 | – | 12,000 | +100.0% | 0.94% | – |
| New | ALLERGAN INCcall | $3,332,000 | – | 30,000 | +100.0% | 0.93% | – | |
| COST | New | COSTCO WHSL CORP NEW | $3,315,000 | – | 27,854 | +100.0% | 0.92% | – |
| SRCL | New | Stericycle Inc | $3,269,000 | – | 28,139 | +100.0% | 0.91% | – |
| New | Apple Inc | $3,097,000 | – | 5,520 | +100.0% | 0.86% | – | |
| BRCM | New | Broadcom Corpcl a | $2,846,000 | – | 96,000 | +100.0% | 0.79% | – |
| PCP | New | Precision Castparts Corp | $2,833,000 | – | 10,520 | +100.0% | 0.79% | – |
| ORBK | New | Orbotech Ltdord | $2,795,000 | – | 206,754 | +100.0% | 0.78% | – |
| CLVS | New | CLOVIS ONCOLOGY INC | $2,712,000 | – | 45,000 | +100.0% | 0.76% | – |
| SCHW | New | SCHWAB CHARLES CORP NEW | $2,546,000 | – | 97,927 | +100.0% | 0.71% | – |
| ITB | New | ISHARESmsci aust etf | $2,534,000 | – | 102,000 | +100.0% | 0.71% | – |
| NVS | New | NOVARTIS A Gsponsored adr | $2,411,000 | – | 30,000 | +100.0% | 0.67% | – |
| SEE | New | SEALED AIR CORP NEW | $2,384,000 | – | 70,000 | +100.0% | 0.66% | – |
| New | B/E Aerospace Inc | $2,324,000 | – | 26,700 | +100.0% | 0.65% | – | |
| PCLN | New | PRICELINE COM INC | $2,296,000 | – | 1,975 | +100.0% | 0.64% | – |
| FL | New | Foot Locker Inc | $2,284,000 | – | 55,119 | +100.0% | 0.64% | – |
| AMBI | New | AMBIT BIOSCIENCES CORP | $2,256,000 | – | 233,995 | +100.0% | 0.63% | – |
| RPRX | New | REPROS THERAPEUTICS INC | $2,196,000 | – | 120,000 | +100.0% | 0.61% | – |
| CSX | New | CSX Corp | $2,110,000 | – | 73,325 | +100.0% | 0.59% | – |
| CPRT | New | Copart Inc | $2,096,000 | – | 57,200 | +100.0% | 0.58% | – |
| WAG | New | Walgreen Co | $2,028,000 | – | 35,300 | +100.0% | 0.56% | – |
| New | SodaStream International Ltdput | $1,986,000 | – | 40,000 | +100.0% | 0.55% | – | |
| XLRN | New | ACCELERON PHARMA INC | $1,980,000 | – | 50,000 | +100.0% | 0.55% | – |
| AERI | New | AERIE PHARMACEUTICALS INC | $1,976,000 | – | 110,000 | +100.0% | 0.55% | – |
| LVS | New | Las Vegas Sands Corp | $1,946,000 | – | 24,677 | +100.0% | 0.54% | – |
| CYTR | New | CYTRX CORP | $1,944,000 | – | 310,000 | +100.0% | 0.54% | – |
| BLUE | New | BLUEBIRD BIO INC | $1,939,000 | – | 92,435 | +100.0% | 0.54% | – |
| MDVN | New | MEDIVATION INC | $1,915,000 | – | 30,000 | +100.0% | 0.53% | – |
| YHOO | New | YAHOO INC | $1,785,000 | – | 44,138 | +100.0% | 0.50% | – |
| SILC | New | Silicom Ltdord | $1,729,000 | – | 37,821 | +100.0% | 0.48% | – |
| KBIO | New | KALOBIOS PHARMACEUTICALS INC | $1,702,000 | – | 385,000 | +100.0% | 0.47% | – |
| MDCO | New | MEDICINES CO | $1,699,000 | – | 44,000 | +100.0% | 0.47% | – |
| TLOG | New | TETRALOGIC PHARMACEUTICALS C | $1,666,000 | – | 175,000 | +100.0% | 0.46% | – |
| PTLA | New | PORTOLA PHARMACEUTICALS INC | $1,634,000 | – | 63,471 | +100.0% | 0.46% | – |
| SRPT | New | SAREPTA THERAPEUTICS INC | $1,630,000 | – | 80,000 | +100.0% | 0.45% | – |
| New | ACADIA PHARMACEUTICALS INC | $1,499,000 | – | 60,000 | +100.0% | 0.42% | – | |
| INFI | New | INFINITY PHARMACEUTICALS INC | $1,381,000 | – | 100,000 | +100.0% | 0.38% | – |
| ONTX | New | ONCONOVA THERAPEUTICS INC | $1,378,000 | – | 120,000 | +100.0% | 0.38% | – |
| XNCR | New | XENCOR INC | $1,353,000 | – | 148,000 | +100.0% | 0.38% | – |
| PRTA | New | PROTHENA CORP PLC | $1,326,000 | – | 50,000 | +100.0% | 0.37% | – |
| ONTY | New | ONCOTHYREON INC | $1,317,000 | – | 748,336 | +100.0% | 0.37% | – |
| CMG | New | Chipotle Mexican Grill Inc | $1,305,000 | – | 2,450 | +100.0% | 0.36% | – |
| PTCT | New | PTC THERAPEUTICS INC | $1,249,000 | – | 73,583 | +100.0% | 0.35% | – |
| TRGT | New | TARGACEPT INC | $1,245,000 | – | 300,000 | +100.0% | 0.35% | – |
| RDWR | New | RADWARE Ltdord | $1,209,000 | – | 67,268 | +100.0% | 0.34% | – |
| ISIS | New | ISIS PHARMACEUTICALS INC | $1,195,000 | – | 30,000 | +100.0% | 0.33% | – |
| VNDA | New | VANDA PHARMACEUTICALS INC | $1,179,000 | – | 95,000 | +100.0% | 0.33% | – |
| NKE | New | NIKE Inccl b | $1,179,000 | – | 14,994 | +100.0% | 0.33% | – |
| DSCO | New | DISCOVERY LABORATORIES INC N | $1,125,000 | – | 500,000 | +100.0% | 0.31% | – |
| QLTI | New | QLT INC | $1,114,000 | – | 200,000 | +100.0% | 0.31% | – |
| CYTK | New | CYTOKINETICS INC | $1,086,000 | – | 167,000 | +100.0% | 0.30% | – |
| XOMA | New | XOMA CORP DEL | $1,077,000 | – | 160,000 | +100.0% | 0.30% | – |
| THRX | New | THERAVANCE INC | $1,016,000 | – | 28,500 | +100.0% | 0.28% | – |
| ELLO | New | ELLOMAY CAPITAL LIMITED | $955,000 | – | 98,953 | +100.0% | 0.27% | – |
| RNA | New | PROSENSA HLDG N V | $899,000 | – | 192,428 | +100.0% | 0.25% | – |
| INSM | New | INSMED INC | $799,000 | – | 47,000 | +100.0% | 0.22% | – |
| SPNS | New | SAPIENS INTL CORP N V | $793,000 | – | 102,798 | +100.0% | 0.22% | – |
| RNN | New | REXAHN PHARMACEUTICALS INC | $765,000 | – | 1,500,000 | +100.0% | 0.21% | – |
| RLYP | New | RELYPSA INC | $750,000 | – | 30,000 | +100.0% | 0.21% | – |
| JNJ | New | JOHNSON & JOHNSON | $714,000 | – | 7,800 | +100.0% | 0.20% | – |
| ENTA | New | ENANTA PHARMACEUTICALS INC | $690,000 | – | 25,292 | +100.0% | 0.19% | – |
| RIGL | New | RIGEL PHARMACEUTICALS INC | $653,000 | – | 229,100 | +100.0% | 0.18% | – |
| ARQL | New | ARQULE INC | $626,000 | – | 291,100 | +100.0% | 0.17% | – |
| OGXI | New | ONCOGENEX PHARMACEUTICALS IN | $618,000 | – | 74,100 | +100.0% | 0.17% | – |
| CNAT | New | CONATUS PHARMACEUTICALS INC | $565,000 | – | 87,600 | +100.0% | 0.16% | – |
| New | MERRIMACK PHARMACEUTICALS INcall | $533,000 | – | 100,000 | +100.0% | 0.15% | – | |
| New | SYNTA PHARMACEUTICALS CORPcall | $524,000 | – | 100,000 | +100.0% | 0.15% | – | |
| XNPT | New | XENOPORT INC | $518,000 | – | 90,000 | +100.0% | 0.14% | – |
| GERN | New | GERON CORP | $474,000 | – | 100,000 | +100.0% | 0.13% | – |
| New | ARROWHEAD RESH CORP | $217,000 | – | 20,000 | +100.0% | 0.06% | – | |
| OCRX | New | OCERA THERAPEUTICS INC | $193,000 | – | 14,881 | +100.0% | 0.05% | – |
| PTX | New | PERNIX THERAPEUTICS HLDGS IN | $142,000 | – | 56,500 | +100.0% | 0.04% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2014-02-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| TEVA PHARMACEUTICAL-SP ADR | 36 | Q3 2023 | 8.4% |
| MERCK & CO INC NEW | 35 | Q3 2023 | 8.4% |
| NICE Systems Ltd | 27 | Q3 2023 | 4.4% |
| BIOGEN INC | 26 | Q3 2023 | 6.7% |
| AMICUS THERAPEUTICS INC | 26 | Q2 2022 | 4.3% |
| PFIZER INC | 25 | Q3 2023 | 9.2% |
| SAREPTA THERAPEUTICS INC | 25 | Q3 2023 | 3.2% |
| JOHNSON & JOHNSON | 24 | Q3 2023 | 8.0% |
| UNIQURE NV | 23 | Q3 2023 | 1.2% |
| SYNDAX PHARMACEUTICALS INC | 22 | Q3 2023 | 3.9% |
View SPHERA FUNDS MANAGEMENT LTD.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Cyclacel Pharmaceuticals, Inc. | February 06, 2023 | 250,000 | 2.0% |
| Altimmune, Inc. | February 14, 2022 | 1,244,241 | 3.1% |
| Allot Ltd. | February 16, 2021 | 1,129,054 | 3.2% |
| Larimar Therapeutics, Inc. | February 16, 2021 | ? | ? |
| Neos Therapeutics, Inc. | February 16, 2021 | ? | ? |
| Orgenesis Inc. | February 16, 2021 | 525,216 | 0.0% |
| Sio Gene Therapies Inc. | February 16, 2021 | ? | ? |
| X4 Pharmaceuticals, Inc | February 16, 2021 | 250,000 | 0.0% |
| Axovant Gene Therapies Ltd. | February 25, 2020 | 2,931,017 | 8.0% |
| Axovant Gene Therapies Ltd. | February 11, 2020 | 398,540 | 1.8% |
View SPHERA FUNDS MANAGEMENT LTD.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| 13F-HR/A | 2024-02-15 |
| 13F-HR | 2024-02-14 |
| SC 13G | 2024-02-08 |
| SC 13G/A | 2024-02-05 |
| SC 13G/A | 2024-02-05 |
| SC 13G/A | 2024-02-05 |
| SC 13G/A | 2024-02-05 |
| 13F-HR | 2023-11-14 |
| SC 13G | 2023-10-10 |
View SPHERA FUNDS MANAGEMENT LTD.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.